共 50 条
The postoperative Model for End stage Liver Disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers
被引:10
|作者:
Benko, Tamas
[1
]
Gallinat, Anja
[1
]
Minor, Thomas
[1
]
Saner, Fuat H.
[1
]
Sotiropoulos, Georgios C.
[1
]
Paul, Andreas
[1
]
Hoyer, Dieter P.
[1
]
机构:
[1] Univ Essen Duisburg, Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, Essen, Germany
关键词:
extended criteria donor;
liver graft dysfunction;
postoperative Model for End stage Liver Disease;
risk assessment;
EARLY ALLOGRAFT DYSFUNCTION;
SINGLE-CENTER EXPERIENCE;
PRIMARY NONFUNCTION;
GRAFT FUNCTION;
MELD;
RETRANSPLANTATION;
PRESERVATION;
DEFINITION;
ALLOCATION;
RECIPIENTS;
D O I:
10.1097/MEG.0000000000000851
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
Background Recently, the postoperative Model for End stage Liver Disease score (POPMELD) was suggested as a definition of postoperative graft dysfunction and a predictor of outcome after liver transplantation (LT). Aim The aim of the present study was to validate this concept in the context of extended criteria donor (ECD) organs. Patients and methods Single-center prospectively collected data (OPAL study/01/11-12/13) of 116 ECD LTs were utilized. For each recipient, the Model for End stage Liver Disease (MELD) score was calculated for 7 postoperative days (PODs). The ability of international normalized ratio, bilirubin, aspartate aminotransferase, Donor Risk Index, a recent definition of early allograft dysfunction, and the POPMELD was compared to predict 90-day graft loss. Predictive abilities were compared by receiver operating characteristic curves, sensitivity and specificity, and positive and negative predictive values. Results The median Donor Risk Index was 1.8. In all, 60.3% of recipients were men [ median age of 54 (23-68) years]. The median POD1-7 peak-aspartate aminotransferase value was 1052 (194-17 577) U/l. The rate of early allograft dysfunction was 22.4%. The 90-day graft survival was 89.7%. Out of possible predictors of the 90-day graft loss MELD on POD5 was the best predictor of outcome (area under the curve = 0.84). A MELD score of 16 or more on POD5 predicted the 90-day graft loss with a specificity of 80.8%, a sensitivity of 81.8%, and a positive and negative predictive value of 31 and 97.7%. Conclusion A MELD score of 16 or more on POD5 is an excellent predictor of outcome in ECD donor LT. Routine evaluation of POPMELD scores might support clinical decision-making and should be reported routinely in clinical trials. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:716 / 722
页数:7
相关论文